EFFECTS OF A ZINC-CONTAINING BIOCOMPOSITE ON THE PARIETAL MICROFLORA OF THE COLON

DOI: https://doi.org/10.29296/25419218-2019-04-08
Issue: 
4
Year: 
2019

A.D. Kim(2), S.A. Lepekhova(1), E.V. Koval(2, 4), Ya.A. Kostyro(3), N.N. Trofimova(3), E.Yu. Chashkova(2), K.A. Apartsin1, 2, Yu.I. Pivovarov(2) 1-Irkutsk Research Center, Siberian Branch, Russian Academy of Sciences, 134, Lermontov St., Irkutsk 664033, Russian Federation; 2-Irkutsk Research Center of Surgery and Traumatology, 1, Bortsov Revolutsii St., Irkutsk 664003, Russian Federation; 3-A.E. Favorsky Irkutsk Institute of Chemistry, Siberian Branch, Russian Academy of Sciences, 1. Favorsky St., Irkutsk 664033, Russian Federation; 4-Irkutsk State Medical Academy of Postgraduate Education, 100, Yubileinyi Microdistrict, Irkutsk 664079, Russian Federation

Introduction. The development of intestinal dysbiosis is one of the components in the pathogenesis of inflammatory bowel diseases. A zinc-containing biocomposite (L15) has been designed, which is a hydrophobic rectal ointment. Its composition contains a zinc-containing metal complex dihydroquercetin derivative that has antimicrobial and prebiotic properties. Objective: to assess the qualitative and quantitative changes in the composition of the parietal microflora of the animal colon after rectal administration of the zinc-containing biocomposite in the presence of induced ulcerative colitis. Material and methods. The study was conducted on 54 male Wistar rats divided into 2 groups. Ulcerative colitis was induced by the original procedure. The animals underwent general clinical observation and determination of the quantitative and qualitative composition of the parietal microflora of the distal colon. Results. The rectal administration of a zinc-containing biocomposite to the animals with simulated ulcerative colitis after 10 days led to maintenance of a high level of the representatives of obligate bacteria, such as Bifidobacterium spp. and Lactobacillus spp., which was 47.6% each in progressive disorders with the development of dysbiosis in the parietal microflora of the colon in the control group. Conclusion. In all experimental periods, the changes in the qualitative and quantitative composition of the parietal microflora of the colon in the experimental animals treated with the test zinc-containing biocomposite for a simulated ulcerative lesion of the colon mucosa were positive compensatory as a significant increase in the concentration of Bifidobacterium spp. at 10 days of the experiment and proceeded without the opportunistic microflora.

Keywords: 
ulcerative colitis
microflora
zinc-containing biocomposite
rectal ointment

References: 
  1. Yi-Zhen Zhang, Yong-Yu Li. Inflammatory bowel disease: Pathogenesis, World J. Gastroenterol, 2014 January 7; 20 (1): 91–9. https://doi.org/10.3748/wjg.v20.i1.91
  2. Gerasimidis K., Bertz M., Hanske L. et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn’s disease during enteral nutrition. Inflamm. Bowel. Dis. 2014; 20 (5): 861–71. https://doi.org/10.1097/MIB.0000000000000023
  3. Arribas B., Suárez-Pereira E., Ortiz Mellet C. et al. Di-D-fructose dianhydride-enriched caramels: effect on colon microbiota, inflammation, and tissue damage in trinitrobenzenesulfonic acid-induced colitic rats. J. Agric. Food Chem., 2010; 58 (10): 6476–84. https://doi.org/10.1021/jf100513j
  4. Nishimura T., Andoh A., Hashimoto T. et al. Cellobiose prevents the development of dextran sulfate odium (DSS)-induced experimental colitis. J. Clin.Biochem.Nutr., 2010; 46 (2): 105–10. https://doi.org/10.3164/jcbn.09-72
  5. Benjamin J.L., Hedin C.R., Koutsoumpas A. et al. Randomised, doubleblind, placebo-controlled trial of fructo-oligosaccharides in active Crohn’s disease. Gut. 2011; 60 (7): 923–9. https://doi.org/10.1136/gut.2010.232025
  6. Rogovskij B.C., Rozenfel'd M.A., Razumovskij S.D. i dr. Otsenka sposobnosti digidrokvertsetina ingibirovat' okislenie fibrinogena ozonom. Eksperimental'naja i klinicheskaja farmakologija, 2013; 76 (3): 23–6. https://doi.org/10.30906/0869-2092-2013-76-3-23-26 [Rogovskii V.S., Rozenfeld M.A., Razumovskii S.D. et al. Estimating ability of dihydroquercetin to inhibit oxidation of fibrinogen by ozone. Eksperimental'naya i klinicheskaya farmakologiya. 2013; 76 (3): 23-26. https://doi.org/10.30906/0869-2092-2013-76-3-23-26 (in Russian)]
  7. Fomichev JuL., Puchkov Ju.N., Shajdullina R.G. i dr. Biopolimer drevesiny digidrokvertsetin – perspektivnaja biologicheski aktivnaja kormovaja dobavka dlja teljat i porosjat. Praktik, 2005; 11–2: 52–5. [Fomichev Yu.L., Puchkov Yu.N., Shaydullina R.G. et al. Biopolymer wood dihydroquercetin is a promising biologically active feed additive for calves and piglets. Praktik, 2005; 11-12: 52–5 (in Russian)].
  8. Trofimova N.N., Babkin V.A., Stolpovskaja E.V. Sposob poluchenija mono- i biligandnyh kompleksnyh soedinenij ionov dvuhvalentnyh metallov - tsinka, medi (II) i kal'tsija, s digidrokvertsetinom, obladajuschih usilennoj antioksidantnoj aktivnost'ju. Patent RF 2553428. Bjulleten' № 16, 10.06.2015: 14. [Trofimova N.N., Babkin V.A., Stolpovskaya E.V. Method for the preparation of mono- and biligand complex compounds of divalent metal ions - zinc, copper (II) and calcium, with dihydroquercetin, which have enhanced antioxidant activity. Patent RF 2553428. Bul. № 16; 10.06.2015: 14 (in Russian)].
  9. Kostyro Ja.A., Davaa V.V., Gogol' E.S. i dr. Farmatsevticheskaja kompozitsija dlja proizvodstva mazej, obladajuschaja protivovospalitel'noj i ranozazhivljajuschej aktivnostjami, stimulirujuschaja rost volosjanyh follikulov na osnove voska kory listvennitsy sibirskoj i Gmelina. Patent RF 2582984. Opublikovano 06.04.2016. [Kostyro Y.A., Davaa V.V., Gogol E.S. et al. Pharmaceutical composition for the production of ointments, which possesses anti-inflammatory and wound-healing activities, stimulating the growth of hair follicles based on wax of the Siberian and Gmelin cortex. Patent RF 2582984. Opublikovano 04.06.2016 (in Russian)].
  10. Kolhir V.K., Tjukavkina N.A., Baginskaja A.I., Mineeva M.F. K otsenke farmakologicheskih svojstv arabinogalaktana. III Rossijskij Natsional'nyj Kongress «Chelovek i lekarstvo». Tezisy dokladov. M., 1996; 27. [Kolkhir V.K., Tyukavkina N.A., Baginskaya A.I., Mineeva M.F. To assess the pharmacological properties of arabinogalactan. III Rossiyskiy Natsionalnyy Congress «Chelovek i lekarstvo». Tezicy dokladov. Moscow, 1996; 27 (in Russian)].
  11. Shul'ts E.E., Petrova T.N., Komarova N.I. i dr. Sposob poluchenija rezveratrola iz rastitel'nogo syr'ja. Patent RF 22944919. Himija rastitel'nogo syr'ja, 2008; 4: 83-88. [Schultz EE, Petrova TN., Komarova N.I. et al. Method for obtaining resveratrol from vegetable raw materials. Patent 22944919 RF. Himiya rastitel'nogo syriya, 2008; 4: 83–8 (in Russian)].
  12. Atmaca S., Gül K., Çiçek R. The Effect of Zinc on Microbial Growth. Tr. J. of Medical Sciences, 1998; 28: 595–7.
  13. OST 91500.11.0004-2003. Protokol vedenija bol'nyh. Disbakterioz kishechnika. Prikaz MZ RF № 231 ot 09.06.2003 [OST 91500.11.0004 - 2003. The protocol of patients management. Dysbacteriosis of the intestine. Order of the Ministry of Health of the Russian Federation № 231 of 09.06.2003 (in Russian)].